Portfolio Investments
Madryn invests in innovative and transformative companies that are driving the future of the healthcare industry
At Madryn, we are much more than a provider of capital. We are business builders and thoughtful strategic partners that possess extensive healthcare industry experience, knowledge and expertise. We take pride in collaborating and working alongside management teams to help them scale their companies, navigate operational challenges, and support their long-term growth.
Veracyte (Nasdaq: VCYT) is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. The company’s growing menu of genomic tests leverage advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures and quicken time to appropriate treatment. The company’s tests in thyroid cancer, lung cancer, breast cancer and idiopathic pulmonary fibrosis are available to patients and its lymphoma subtyping test is in development. With Veracyte’s exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide.